SPONSOR
Gruppo Italiano Malattie EMatologiche dell'Adulto
Total Trials
4
Recruiting
4
Phases
Phase 3
Gruppo Italiano Malattie EMatologiche dell'Adulto is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including AML, Adult, Myelodysplastic Syndromes, Multiple Myeloma, High-risk MDS.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gruppo Italiano Malattie EMatologiche dell'Adulto
How many clinical trials has Gruppo Italiano Malattie EMatologiche dell'Adulto sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Gruppo Italiano Malattie EMatologiche dell'Adulto, of which 4 are actively recruiting participants. These trials cover conditions including AML, Adult, Myelodysplastic Syndromes, Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gruppo Italiano Malattie EMatologiche dell'Adulto research focus on?
Gruppo Italiano Malattie EMatologiche dell'Adulto clinical trials span AML, Adult, Myelodysplastic Syndromes, Multiple Myeloma, High-risk MDS. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gruppo Italiano Malattie EMatologiche dell'Adulto clinical trial?
To participate in a Gruppo Italiano Malattie EMatologiche dell'Adulto trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gruppo Italiano Malattie EMatologiche dell'Adulto trials with current recruitment status updated daily.
Clinical Trials by Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT05839392
Recruiting
Novel Approaches to Target MECOM/EVI1 in AML
AML, Adult
NCT04587856
Recruiting
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
Myelodysplastic Syndromes
NCT06933277
Recruiting
Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
Multiple Myeloma
NCT04184505 Phase 3
Recruiting
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
High-risk MDS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology